retatrutide parkinson's disease trial nct Results: 28.3% Weight Loss Data Emerging therapies in Parkinson disease

Among adults diagnosed with type 2 diabetes, historically the primary prescribing indication, GLP-1 medication use reached 26.5% in 2024

Semaglutide (Wegovy, Ozempic) Semaglutide injections are usually the least expensive option and is effective for many patients

Maintaining this is difficult with diet alone, but retatrutides effects make it more attainable

Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes

Higher levels of the stress hormone cortisol can push hair follicles out of the growth phase and into a wave of shedding

You may start with the lowest dose of a GLP-1 after your first visit and gradually increase as tolerated, based on follow-up visits